LITESPARK-024: Randomized phase 1/2 study of belzutifan with or without palbociclib for treatment of advanced renal cell carcinoma (RCC).

被引：0
作者：
McDermott, David F.
Peer, Avivit
Agarwal, Neeraj
Atkins, Michael B.
Cornell, Jerry
Perini, Rodolfo F.
Grossmann, Kenneth F.
Gurney, Howard
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA USA
[2] Rambam Hlth Care Campus, Haifa, Israel
[3] Huntsman Canc Inst, Salt Lake City, UT USA
[4] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[5] Merck & Co Inc, Rahway, NJ USA
[6] Westmead Hosp, Sydney, NSW, Australia
[7] Macquarie Univ, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4603
引用
收藏
页数：1
相关论文
共 50 条
[41]   Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC) [J].
Shahani, Rohan ;
Kwan, Kevin G. ;
Kapoor, Anil .
DRUG HEALTHCARE AND PATIENT SAFETY, 2010, 2 :85-91
[42]   Predictive and prognostic factors in a phase III study of pazopanib in patients with advanced renal cell carcinoma (RCC) [J].
Sternberg, C. ;
Davis, I. ;
Wagstaff, J. ;
Hawkins, R. ;
Chen, M. ;
Ding, J. .
EJC SUPPLEMENTS, 2009, 7 (02) :424-424
[43]   A phase 1/2 study to evaluate the efficacy and safety of HB0025 monotherapy for patients (pts) with advanced renal cell carcinoma (RCC) [J].
Qu, Yuan-Yuan ;
Ye, Dingwei ;
Bian, Xiaojie ;
Han, Weiqing ;
Liu, Kan ;
Dai, Tao ;
Sun, Yuping ;
Bian, Jiasheng ;
Dang, Qi ;
Sun, Meili ;
Wang, Zhen ;
Zhang, Jian ;
Zhou, Huan ;
Gao, Zhenyuan ;
Zhu, Xiangyang ;
Yang, Yongmin ;
Chen, Juan ;
Yang, Yang ;
Wang, Junning ;
Cai, Ye .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[44]   The efficacy and safety of linomide in the treatment of renal cell carcinoma [RCC]. An EORTC phase II study [J].
Pawinski, A ;
vanOosterom, AT ;
deMulder, PHM ;
Stoter, G ;
Svedberg, A .
EUROPEAN JOURNAL OF CANCER, 1995, 31A :461-461
[45]   Phase 2 study of combination tivozanib and nivolumab in advanced non-clear cell renal cell carcinoma (RCC): FORTUNE trial [J].
Nguyen, Charles B. ;
Vaishampayan, Ulka N. ;
Campbell, Matthew T. ;
Hammers, Hans J. ;
Brooks, Roserika ;
Solley, Travis ;
Wood, Lauren Michelle ;
Jonasch, Eric ;
Alva, Ajjai Shivaram .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[46]   Preliminary phase 2 results of ABT-751 in subjects with advanced renal cell carcinoma (RCC) [J].
Hagey, AE ;
Figlin, RA ;
Moldawer, N ;
Sosman, JA ;
Chi, KN ;
Medina, DM ;
Meek, KA ;
Cernohous, P ;
Gordon, GB .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :403S-403S
[47]   Phase 1 LITESPARK-001 (MK-6482-001) study of belzutifan in advanced solid tumors: Update of the clear cell renal cell carcinoma (ccRCC) cohort with more than 3 years of total follow-up. [J].
Jonasch, Eric ;
Bauer, Todd Michael ;
Papadopoulos, Kyriakos P. ;
Plimack, Elizabeth R. ;
Merchan, Jaime R. ;
McDermott, David F. ;
Michaelson, M. Dror ;
Appleman, Leonard Joseph ;
Roy, Ananya ;
Liu, Yanfang ;
Perini, Rodolfo F. ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[48]   The DART Study: A phase 2 randomized double-blind study of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma (RCC) [J].
Voss, M. H. ;
Plimack, E. ;
Rini, B. ;
Bhatt, R. S. ;
Alter, R. ;
Beck, J. T. ;
Mutyaba, M. ;
Pappas, K. ;
Wilson, D. ;
Zhang, X. ;
Sun, J. ;
Glasser, C. ;
Sherman, M. L. ;
Pandya, S. S. ;
Atkins, M. B. .
BJU INTERNATIONAL, 2015, 116 :22-23
[49]   The DART Study: A phase 2 randomized double-blind study of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma (RCC). [J].
Voss, Martin Henner ;
Plimack, Elizabeth R. ;
Rini, Brian I. ;
Atkins, Michael B. ;
Alter, Robert ;
Bhatt, Rupal Satish ;
Beck, J. Thaddeus ;
Mutyaba, Musa ;
Pappas, Kristen M. ;
Wilson, Dawn ;
Zhang, Xiaosha ;
Sherman, Matthew L. ;
Pandya, Shuchi Sumant .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[50]   Final results of a Phase II randomised study of cediranib (RECENTIN™) in patients with advanced renal cell carcinoma (RCC) [J].
Mulders, P. ;
Hawkins, R. ;
Nathan, P. ;
de Jong, I. ;
Osanto, S. ;
Porfiri, E. ;
Protheroe, A. ;
Mookerjee, B. ;
Pike, L. ;
Gore, M. E. .
EJC SUPPLEMENTS, 2009, 7 (03) :21-21
12345